Company: RGNX
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0000950170-25-069237
Chunk: 0

Company: REGENXBIO Inc.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 1
Chunk 0
---
REGENXBIO INC.

CONSOLIDATED BALANCE SHEETS

(unaudited)

(in thousands, except per share data)

     March 31, 2025

     December 31, 2024

     Assets

     Current assets

     Cash and cash equivalents
      
     $
     130,104

     $
     57,526

     Marketable securities

     137,765

     177,161

     Accounts receivable

     18,192

     20,473

     Prepaid expenses

     11,094

     9,067

     Other current assets

     16,082

     13,774

     Total current assets

     313,237

     278,001

     Marketable securities

     4,858

     10,179

     Accounts receivable

     1,208

     474

     Property and equipment, net

     114,497

     117,589

     Operating lease right-of-use assets

     52,112

     53,716

     Restricted cash

     2,030

     2,030

     Other assets

     2,987

     4,000

     Total assets
      
     $
     490,929

     $
     465,989

     Liabilities and Stockholders’ Equity

     Current liabilities

     Accounts payable
      
     $
     19,044

     $
     22,798

     Accrued expenses and other current liabilities

     23,597

     38,070

     Deferred revenue

     13,588

     115

     Operating lease liabilities

     7,942

     7,902

     Liability related to sale of future royalties

     42,560

     34,309

     Total current liabilities

     106,731

     103,194

     Deferred revenue

     26,297

     —

     Operating lease liabilities

     71,906

     74,131

     Liability related to sale of future royalties

     11,118

     25,378

     Other liabilities

     680

     3,635

     Total liabilities

     216,732

     206,338

     Stockholders’ equity

     Preferred stock; $0.0001 par value; 10,000